Well Well, finally ,...Patience is a virtue, It looks to me that at this rate that by 2020 all losses would have truly and completely been covered and we will be in the green pound-seats 2021 even if they don't get another company on-board buying our raw material.
But we all know that once the floodgates open and all the approvals and the FDA checks sheets have been met there will certainly be more who want to jump on-board.
So breakeven may even be closer to 2nd quarter 2020 (Really Hopeful here )
What is encouraging is that the plant will not even be running at 50% capacity to achieve those figures currently forecast for 2019, a couple of more off-take agreements from some Chinese players could significantly increase production requirements.
After all it is the single biggest "Natural Products" market in the world.
All this is my opinion and not a trading recommendation. ( In fact please limit your buy of this stock so I can get more at the bargain basement prices when I have more cash on hand, before the refinery changes to the profit bearing workhorse it was built to become) IMO- DYOR. This has always been an LT stock for me.
- Forums
- NZX - By Stock
- SEA
- Ann: SeaDragon provides forecast and funding update
Ann: SeaDragon provides forecast and funding update, page-2
Featured News
Add SEA (NZSX) to my watchlist
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online